Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Medicine|December 21, 2023
Clinicopathological characteristics and treatment outcomes of advanced SMARCA4-deficient thoracic tumorsAnni Wang, Yueping Jin, Zhengqi Cao, et al.
Translational Lung Cancer Research|August 9, 2024
Pathological complete response to neoadjuvant lorlatinib in a patient with stage IIIA <i>ALK</i>-positive non-small cell lung cancer: a case reportLi Lu, Zhengqi Cao, Anni Wang, et al.
ACS Omega|May 13, 2024
Reduction in Marine Primary Productivity in the Early Cambrian Nanhua Basin, South ChinaChengsheng Jin, Zihu Zhang, Meng Cheng, et al.
Frontiers in Immunology|February 12, 2024
ADGRE5-centered Tsurv model in T cells recognizes responders to neoadjuvant cancer immunotherapyJian Li, Zhouwenli Meng, Zhengqi Cao, et al.
Biomarker Research|March 15, 2025
NLRP4 unlocks an NK/macrophages-centered ecosystem to suppress non-small cell lung cancerZhouwenli Meng, Jian Li, Hui Wang, et al.
Translational Lung Cancer Research|May 22, 2026
Association of PD-L1 expression and clinical outcomes in ROS1-rearranged advanced non-small cell lung cancer treated with entrectinibLixuan Chen, Wenhui Shi, Zhengqi Cao, et al.
Cell Reports. Medicine|March 8, 2025
Interferon-γ-stimulated antigen-presenting cancer-associated fibroblasts hinder neoadjuvant chemoimmunotherapy efficacy in lung cancerZhengqi Cao, Zhouwenli Meng, Jian Li, et al.
Annals of Surgical Oncology|August 16, 2023
Neoadjuvant Chemoimmunotherapy Increases Tumor Immune Lymphocytes Infiltration in Resectable Non-small Cell Lung CancerTianxiang Chen, Zhengqi Cao, Yingjia Sun, et al.
Pageof 1